Bioanalysis of Cannabinoids
An LC-MS team specializing in tailored assays for precise cannabinoid PK measurements.
Cannabinoids are a class of compounds that have been utilized extensively due to the breadth of their therapeutic potential.
Resolian’s LC-MS team provides significant expertise in the development and validation of bespoke LC-MS assays to measure the pharmacokinetics (PK) of cannabinoids from early-stage pre-clinical dog, rat and mouse studies up to regulated GCP studies.
The team’s experience of the CBD and THC molecules and their metabolites covers numerous matrices – some assays include up to 8 analytes in a single analysis with sensitivity down to 0.125 ng/mL.
In addition to these, Resolian has developed and validated a variety of proprietary methods across a broad range of species and matrices.
Reach out to us directly to learn more about Resolian’s Bioanalysis of Cannabinoids services.
